P
Priothera
0 followers
Priothera is developing the orally applied sphingosine 1 phosphate (S1P) receptor modulators for haematological malignancies.
Org chart
Florent Gros
CEO & Founder
Florent Gros
Collapse
Elisabeth Kueenburg
Chief Medical Officer
Stephan Oehen
Chief Operating Officer & Founder
Philippe Lievre
Chief Business Officer & Founder
Brice Suire
Chief Financial Officer & Founder
Karen Von Graevenitz
Head of Regulatory Affairs
Simone Dertschnig
Head of Research
Frédéric David
Head Technical Development
Board & advisors
Manus Rogan
Chair
Dhaval Patel
Director
Marten Steen
Director
Henry Skinner
Director
Lionel Carnot
Director
Christoph Bucher
Head of Clinical Advisory Board & Founder
Simone Seiter
Head of Commercial & Scientific Advisory Board & Founder